key: cord-0736488-2yxa0cb7
authors: Jones, D; Barham, L
title: POSA233 The Indirect Health Economic Consequences of the COVID-19 Pandemic on English Hospitals: A Scoping Review
date: 2022-01-31
journal: Value in Health
DOI: 10.1016/j.jval.2021.11.748
sha: 7f3b2264bd49533a34492b00d1f9333acd148816
doc_id: 736488
cord_uid: 2yxa0cb7

Objectives: To identify and analyse trends on emerging literature on the indirect health economic consequences of the COVID-19 pandemic on English hospitals. Methods: A scoping review based upon searches in Embase, MEDLINE, Web of Science, and Google Scholar. Search concepts included “COVID-19” AND “hospital outcomes of health economic consequence” AND “England” AND “indirect” with searches conducted during 8/5/2021 and 9/5/2021. Literature was screened for relevance. Standard bibliographical information, NHS region, sample size, patient population, data source, Covid-19 time periods (pre and during pandemic), and nature of health economic consequence and direction was ed. Narrative synthesis as described by Popay et al. (2006) was used to collate, summarise and report findings consistent with Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) Checklist (Tricco et al. 2018). Results: 502 records were identified for screening with 20 articles included. Seventeen articles reported a decrease in admissions, six of ten articles reported a fall in length of stay, four in ten an increase in length of stay. Four of twelve articles reported an increase in mortality, with eight finding similar rates of mortality pre versus during the pandemic. Conclusions: Understanding the impact of the pandemic on hospital activity as well as the impact on patients is an active area of research. Hospital admissions fell, but the impact on length of stay and inpatient mortality is mixed. Stricter admission policies and hospital avoidance by patients may have driven changes. Interpretation of findings is challenging;lower use of hospitals may reflect unmet health needs that could lead to increased healthcare utilisation in the future. Further research is required in larger nationally representative samples, longer time periods and in other settings to identify the health economic consequences of the pandemic.

SCS therapy using rechargeable neurostimulators in patients with chronic pain and failed back surgery suggests benefits for both patient and payer.

Arku D, Felix M, Warholak T, Axon D University of Arizona, Tucson, AZ, USA Objectives: Program of All-Inclusive Care for the Elderly (PACE) provides comprehensive medical and social services to community-dwelling older adults. Uncontrolled studies indicate PACE participants have positive outcomes. This scoping review aimed to review published studies that compared PACE outcomes to other similar programs. Methods: We used a scoping strategy to search for articles published between January 1, 1997 and March 12, 2021 . Studies were included if they: were written in English; set in the United States; evaluated PACE and a comparator program; and reported any economic, clinical, or humanistic outcomes. We searched nine electronic databases. Two reviewers independently screened abstracts and extracted data from relevant articles using standardized forms and resolved discrepancies through consensus. Results: From 545 articles identified; five studies were included (most did not have a comparator group). Example outcomes included: risk adjusted median PACE survival was 4.2 years, 2.3 years in a nursing home (NH) and 3.5 years in a waiver program for the elderly and disabled in one study (p=0.015 Methods: A scoping review based upon searches in Embase, MEDLINE, Web of Science, and Google Scholar. Search concepts included "COVID-19" AND "hospital outcomes of health economic consequence" AND "England" AND "indirect" with searches conducted during 8/5/2021 and 9/5/2021. Literature was screened for relevance. Standard bibliographical information, NHS region, sample size, patient population, data source, Covid-19 time periods (pre and during pandemic), and nature of health economic consequence and direction was abstracted. Narrative synthesis as described by Popay et al. (2006) was used to collate, summarise and report findings consistent with Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) Checklist (Tricco et al. 2018) . Results: 502 records were identified for screening with 20 articles included. Seventeen articles reported a decrease in admissions, six of ten articles reported a fall in length of stay, four in ten an increase in length of stay. Four of twelve articles reported an increase in mortality, with eight finding similar rates of mortality pre versus during the pandemic. Conclusions: Understanding the impact of the pandemic on hospital activity as well as the impact on patients is an active area of research. Hospital admissions fell, but the impact on length of stay and inpatient mortality is mixed. Stricter admission policies and hospital avoidance by patients may have driven changes. Interpretation of findings is challenging; lower use of hospitals may reflect unmet health needs that could lead to increased healthcare utilisation in the future. Further research is required in larger nationally representative samples, longer time periods and in other settings to identify the health economic consequences of the pandemic.

Boeger S, 1 Busink E, 1 Dewsnap G, 2 Basnayake K, 2 Beaumont M 2 1 Fresenius Medical Care, Bad Homburg, Germany, 2 Fresenius Medical Care (UK) Ltd., Huthwaite, UK Objectives: Dialysis patients require continuity of life-sustaining care and are clinically extremely vulnerable to COVID-19. The pandemic challenged service providers to re-examine delivery of care. This has provided opportunities to reset services to support patients and deliver value-based healthcare. Here we examine whether a large global kidney care network adds value from a clinical and economic perspective to the UK setting during the COVID-19 pandemic. Methods: A systematic literature review (SLR) was performed to assess the added value of large care networks from patient, clinical, organisational and economic perspectives. The results of the SLR were then applied to the specific case study of measures taken during the pandemic in a large dialysis network in the UK. Results: The SLR showed that large care networks improve survival rates, improve management of the patient pathway and reduce length of hospitalisation, contributing to sustainability of healthcare systems. These findings are attributable to swift exchange of information and best practices, ensuring continuity of care and optimal care. Similar outcomes were found in the case study of the dialysis care network in the UK. Less than 24% of the in-centre patients within this network were tested positive for COVID-19 through PCR Testing and the mortality rate of these patients was recorded at 17%. Registry data indicate an overall mortality of 19% for UK in-centre patients. Larger care networks can rapidly adapt to guidance, optimise clinic infrastructure, isolate patients and implement contingency plans to deliver safe care to patients and minimise risk to staff. This can be translated into clear economic benefits, providing value-based care in the most extreme situations. Conclusions: Large care networks facilitate bestpractice learning and exchange, leading to rapid and adaptable responses to threats such as COVID-19. Overall, reduced mortality and hospitalisation rates and the ensured continuity of care translates into cost-effective care provision. Objectives: Hospitalization at home (HAH) is a French specific organization delivering hospital care at home. As part of a national ambulatory care policy, HAH for cancer intravenous treatments is becoming a priority. This work aims to describe the specificities of ICI infusion at home. Methods: Through national hospital database (PMSI), all patients with at least one ICI infusion in 2019 were identified. Patients' characteristics and ICI infusion specificities in hospitals and in HAH were described. Patients' journeys (time to infusion in HAH, time spent in HAH protocols, alternation of infusion in HAH and in hospitals after HAH infusion initiation) were retrospectively analyzed (maximum of 5-year prior period) using swimmer plots and clustering algorithms. Results: In 2019, 36,526 patients received ICI at least once in hospitals including 60 who had infusions at home. Patients treated at home were 62.2 years old (65.5 yo in hospitals) and 61.7% male (67.4% in hospitals). HAH's patients suffered from lung cancer (77%; 61% in hospitals) and melanoma (23%; 14% in hospitals). HAH patients were mainly treated with nivolumab (58%, 54% in hospitals). Seven out of 22 French regions experienced home ICI infusion (min:1; max:21 patients). Average time from first infusion in hospitals to HAH initiation was close to one year (341 days, [95%CI 268-413]) and average time spent between first and last infusion in HAH was 115 days [95%CI 80-150]). Two types of HAH management protocol were observed: 'All infusions in HAH' and 'Alternation of infusions in HAH and hospitals. Conclusions: This first study on ICI infusion at home through HAH highlights its limited use in France and the heterogeneity of the patients' journey. In the context of the COVID-19 epidemic, a greater number of patients infused with ICI at home is expected. An update of this study in 2020 would be of interest.

Methods: This was a retrospective analysis of patient charts reviewed by treating physicians in EU4 and UK from 01/2018-12/2020 in the IQVIA Oncology Dynamics database, including adults (aged $21 years) with confirmed aNSCLC (stage IIIB/C or IV) without actionable oncogenic driver mutations and with Eastern Cooperative Oncology Group (ECOG) status of 0 or 1. 1L maintenance therapy (1LMT) and second-line (2L) Tx characteristics were analyzed. Results: In patients receiving 1LMT at time of data collection